151 related articles for article (PubMed ID: 36194187)
1. Intrapyloric botulinum toxin injection for functional nausea and vomiting: Just a placebo?
Bolia R
Neurogastroenterol Motil; 2022 Dec; 34(12):e14479. PubMed ID: 36194187
[No Abstract] [Full Text] [Related]
2. Botulinum toxin A for the treatment of delayed gastric emptying.
Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
[TBL] [Abstract][Full Text] [Related]
3. Intrapyloric Botulinum Toxin Injection for Refractory Nausea and Vomiting in Pediatric Patients.
Osgood PT; Essner BS; Fountain L; Sullivan EC; Meegan C; Fortunato JE
J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):726-733. PubMed ID: 37794574
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
Rodriguez L; Rosen R; Manfredi M; Nurko S
Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting.
Hirsch S; Nurko S; Liu E; Rosen R
Neurogastroenterol Motil; 2022 Nov; 34(11):e14428. PubMed ID: 35811408
[TBL] [Abstract][Full Text] [Related]
7. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
[TBL] [Abstract][Full Text] [Related]
8. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis.
Ezzeddine D; Jit R; Katz N; Gopalswamy N; Bhutani MS
Gastrointest Endosc; 2002 Jun; 55(7):920-3. PubMed ID: 12024156
[TBL] [Abstract][Full Text] [Related]
9. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients.
Gil RA; Hwynn N; Fabian T; Joseph S; Fernandez HH
Parkinsonism Relat Disord; 2011 May; 17(4):285-7. PubMed ID: 21296606
[TBL] [Abstract][Full Text] [Related]
11. A systematic review on intrapyloric botulinum toxin injection for gastroparesis.
Bai Y; Xu MJ; Yang X; Xu C; Gao J; Zou DW; Li ZS
Digestion; 2010; 81(1):27-34. PubMed ID: 20029206
[TBL] [Abstract][Full Text] [Related]
12. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
Mueller J
Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
[No Abstract] [Full Text] [Related]
13. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis.
Arts J; Holvoet L; Caenepeel P; Bisschops R; Sifrim D; Verbeke K; Janssens J; Tack J
Aliment Pharmacol Ther; 2007 Nov; 26(9):1251-8. PubMed ID: 17944739
[TBL] [Abstract][Full Text] [Related]
14. Beyond gastric emptying: a "toxic" lesson about gastroparesis.
Pasricha PJ
Am J Gastroenterol; 2008 Feb; 103(2):424-6. PubMed ID: 18289204
[TBL] [Abstract][Full Text] [Related]
15. [New therapeutic approaches to diabetic gastroparesis].
Hummel M; Geigenberger G; Brand J; Ziegler AG; Füchtenbusch M
Med Klin (Munich); 2008 Jul; 103(7):514-8. PubMed ID: 18604486
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A for treatment of refractory gastroparesis.
DeSantis ER; Huang S
Am J Health Syst Pharm; 2007 Nov; 64(21):2237-40. PubMed ID: 17959574
[TBL] [Abstract][Full Text] [Related]
17. Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy.
Clarke JO; Snape WJ
Gastroenterol Clin North Am; 2015 Mar; 44(1):127-36. PubMed ID: 25667028
[TBL] [Abstract][Full Text] [Related]
18. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis.
Wellington J; Scott B; Kundu S; Stuart P; Koch KL
Auton Neurosci; 2017 Jan; 202():56-61. PubMed ID: 27460691
[TBL] [Abstract][Full Text] [Related]
19. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Botulinum toxin in clinical medicine: part II.
Benedetto AV
Clin Dermatol; 2004; 22(1):1-2. PubMed ID: 15158537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
